|1.||Padiath, Quasar S: 1 article (11/2015)|
|2.||Nmezi, Bruce: 1 article (11/2015)|
|3.||Potic, Ana: 1 article (11/2015)|
|4.||Lohmann, Katja: 1 article (01/2015)|
|5.||Wiegers, Karin: 1 article (01/2015)|
|6.||Brænne, Ingrid: 1 article (01/2015)|
|7.||Newcomb, Tara M: 1 article (01/2015)|
|8.||Sweney, Matthew T: 1 article (01/2015)|
|9.||Winkler, Susen: 1 article (01/2015)|
|10.||Wilcox, Robert: 1 article (01/2015)|
|1.||Prostatic Neoplasms (Prostate Cancer)
06/01/1999 - "The VA Cancer of the Prostate Outcomes Study (VA CaPOS) is collecting quality-of-life (QOL) information from prostate cancer patients, spouses, and physicians at six VA medical centers. "
06/01/1999 - "The VA CaPOS provides useful information on health status and patient satisfaction of VA prostate cancer patients. "
|2.||Congenital Abnormalities (Deformity)
|3.||Parkinsonian Disorders (Parkinsonism)
|5.||Nervous System Diseases (Neurological Disorders)
01/01/2015 - "The phenotypic spectrum of ATP1A3-related neurological disorders continues to expand beyond the distinct yet overlapping phenotypes in patients with AHC, RDP, and CAPOS syndromes. "
01/01/2015 - "While classically defined phenotypes associated with AHC, RDP, and CAPOS syndromes are distinct, common elements among ATP1A3-related neurological disorders include characteristic episodic neurological symptoms and signs that vary in severity, duration, and frequency of occurrence. "